Kristopher A. Kerns

Kristopher A. Kerns

Auto-generated profile, based on publicly available information

Kristopher A. Kerns

Department of Periodontics, University of Washington

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2020 in eLife
Verified
Journal Article
Open access
JAJonathan Y An
Jonathan Y An
KKKristopher A Kerns
Kristopher A Kerns
AOAndrew Ouellette
Andrew Ouellette
LRLaura Robinson
Laura Robinson
H. Douglas MorrisH. Douglas Morris
H. Douglas Morris
MKMatt Kaeberlein
Matt Kaeberlein
Periodontal disease is an age-associated disorder clinically defined by periodontal bone loss, inflammation of the specialized tissues that surround and support the tooth, and microbiome dysbiosis. Currently, there is no therapy for reversing periodontal disease, and treatment is generally restricted to preventive measures or tooth extraction. The FDA-approved drug rapamycin slows aging and extends lifespan in multiple organisms, including mice. Here, we demonstrate that short-term treatment with rapamycin rejuvenates the aged oral cavity of elderly mice, including regeneration of periodontal bone, attenuation of gingival and periodontal bone inflammation, and revertive shift of the oral microbiome toward a more youthful composition. This provides a geroscience strategy to potentially rejuvenate oral health and reverse periodontal disease in the elderly.

30 June 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SBShatha Bamashmous
Shatha Bamashmous
GKGeorgios Kotsakis
Georgios Kotsakis
KKKristopher A. Kerns
Kristopher A. Kerns
BLBrian G. Leroux
Brian G. Leroux
CZCamille Zenobia
Camille Zenobia
RDRichard P. Darveau
Richard P. Darveau
Oral commensal bacteria actively participate with gingival tissue to maintain healthy neutrophil surveillance and normal tissue and bone turnover processes. Disruption of this homeostatic host–bacteria relationship occurs during experimental gingivitis studies where it has been clearly established that increases in the bacterial burden increase gingival inflammation. Here, we show that experimental gingivitis resulted in three unique clinical inflammatory phenotypes (high, low, and slow) and reveal that interleukin-1β, a reported major gingivitis-associated inflammatory mediator, was not associated with clinical gingival inflammation in the slow response group. In addition, significantly higher levels of Streptococcus spp. were also unique to this group. The low clinical response group was characterized by low concentrations of host mediators, despite similar bacterial accumulation and compositional characteristics as the high clinical response group. Neutrophil and bone activation modulators were down-regulated in all response groups, revealing novel tissue and bone protective responses during gingival inflammation. These alterations in chemokine and microbial composition responses during experimental gingivitis reveal a previously uncharacterized variation in the human host response to a disruption in gingival homeostasis. Understanding this human variation in gingival inflammation may facilitate the identification of periodontitis-susceptible individuals. Overall, this study underscores the variability in host responses in the human population arising from variations in host immune profiles (low responders) and microbial community maturation (slow responders) that may impact clinical outcomes in terms of destructive inflammation. Significance Experimental gingivitis studies where dental hygiene is withheld from select teeth, allowing natural bacterial accumulation, provide a unique opportunity to study the reversible transition from health to inflammatory disease in humans. Longitudinal analysis of both the microbial and host changes during human experimental gingivitis revealed a previously unknown variation in the human host response and microbial succession sequence during inflammation. The significance of our findings can be summarized in two major points. First, the study comprehensively characterizes three different clinical responses—designated high, low, and slow—discerning unique host and microbial features that define each group. Second, we have unveiled previously unrecognized host protective mechanisms to prevent inflammatory bone resorption during reversible gingival inflammation.

2 October 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
KKKristopher A. Kerns
Kristopher A. Kerns
SBShatha Bamashmous
Shatha Bamashmous
EHErik L. Hendrickson
Erik L. Hendrickson
GKGeorgios Kotsakis
Georgios Kotsakis
BLBrian G. Leroux
Brian G. Leroux
JMJeffrey Scott McLean
Jeffrey Scott McLean
Variation in human immune response to the same bacterial or viral pathogen is well established in the literature. Variation in immune response to microbial challenge has also been observed within the human oral cavity. Our recent study focused on characterizing observed variations in microbially induced gingival inflammation—resulting in three distinct clinical Inflammatory Responder Types (IRTs): High-IRT, Low-IRT, and Slow-IRT. Here, we applied a high-resolution temporal multiomic analysis during microbially induced inflammation in order to characterize the effects of localized oral inflammation on distant healthy tissues in young healthy adults. Our results highlight a nonlocalized subclinical effect with alterations in proinflammatory host mediators and an ecological shift toward dysbiosis within the subgingival microbiome in an IRT-dependent manner—despite maintained oral hygiene. Our results provide mechanistic insight into how healthy tissues within humans are influenced by distant localized inflammation and may ultimately become susceptible to disease.

11 November 2020 in Molecular Oral Microbiology
Verified
Journal Article
Open access
PDF file
ELEleanor I. Lamont
Eleanor I. Lamont
AGArchita Gadkari
Archita Gadkari
KKKristopher A. Kerns
Kristopher A. Kerns
TTThao T. To
Thao T. To
DDDiane Daubert
Diane Daubert
JMJeffrey Scott McLean
Jeffrey Scott McLean
Developing a laboratory model of oral polymicrobial communities is essential for in vitro studies of the transition from healthy to diseased oral plaque. SHI medium is an enriched growth medium capable of supporting in vitro biofilms with similar diversity to healthy supragingival inocula; however, this medium does not maintain the diversity of gram‐negative bacteria more associated with subgingival plaque. Here, we systematically modified SHI medium components to investigate the impacts of varying nutrients and develop a medium capable of supporting a specific disease‐state subgingival community. A diseased subgingival plaque sample was inoculated in SHI medium with increasing concentrations of sucrose (0%, 0.1%, 0.5%), fetal bovine serum (FBS) (0%, 10%, 20%, 30%, 50%), and mucin (0.1, 2.5, 8.0 g/L) and grown for 48 hrs, then the 16S rRNA profiles of the resulting biofilms were examined. In total, these conditions were able to capture 89 of the 119 species and 43 of the 51 genera found in the subgingival inoculum. Interestingly, biofilms grown in high sucrose media, although dominated by acidogenic Firmicutes with a low final pH, contained several uncultured taxa from the genus Treponema, information that may aid culturing these periodontitis‐associated fastidious organisms. Biofilms grown in a modified medium (here named subSHI‐v1 medium) with 0.1% sucrose and 10% FBS had a high diversity closest to the inoculum and maintained greater proportions of many gram‐negative species of interest from the subgingival periodontal pocket (including members of the genera Prevotella and Treponema, and the Candidate Phyla Radiation phylum Saccharibacteria), and therefore best represented the disease community.

20 September 2022 in Journal of Bacteriology
Verified
Journal Article
Closed access
EHErik L. Hendrickson
Erik L. Hendrickson
BBBatbileg Bor
Batbileg Bor
KKKristopher A. Kerns
Kristopher A. Kerns
ELEleanor I. Lamont
Eleanor I. Lamont
YCYunjie Chang
Yunjie Chang
JMJeffrey Scott McLean
Jeffrey Scott McLean
Nanosynbacter lyticus type strain TM7x is the first cultivated member of the Saccharibacteria and the candidate phyla radiation (CPR). It was discovered to be ultrasmall in cell size with a highly reduced genome that establishes an obligate epibiotic relationship with its host bacterium.

29 December 2025 in The ISME Journal
Verified
Journal Article
Open access
NNNusrat Nahar
Nusrat Nahar
Pu-Ting DongPu-Ting Dong
Pu-Ting Dong
JTJing Tian
Jing Tian
AGAlex S Grossman
Alex S Grossman
EHErik L Hendrickson
Erik L Hendrickson
XHXuesong He
Xuesong He
Saccharibacteria (formerly TM7) are a group of environmentally diverse, ultrasmall bacteria with highly reduced genomes belonging to Patescibacteria (formerly Candidate Phyla Radiation), a newly identified bacterial lineage accounting for over a quarter of microbial diversity. Nanosynbacter lyticus strain TM7x was isolated from the human oral cavity and was the first culture representative of Saccharibacteria. It displays an obligate episymbiotic lifestyle where TM7x lives on the surface of its bacterial host Schaalia odontolytica strain XH001. Saccharibacteria rely on host bacteria for growth. TM7x multiplies through budding division, and daughter cells can disassociate from host bacteria during their horizontal transmission stage and establish symbiosis with new bacterial hosts. However, how these metabolically constrained symbionts maintain their viability and infectivity during their horizontal transmission phase, when they are disassociated from hosts, remains poorly understood. By applying targeted mutagenesis using recently developed genetic tools for Saccharibacteria, we demonstrate that the TM7x-encoded arginine deiminase system (ADS) plays a critical role in ATP production and impacts TM7x-host bacterium interaction. Furthermore, we present the first empirical evidence showing that TM7x can uptake and utilize glucose via the glycolysis pathway. Glycolysis is particularly important for episymbiont ATP production under anoxic conditions during horizontal transmission between hosts. Our study demonstrates that TM7x employs two ATP-generating metabolic pathways, ADS and glycolysis, to ensure its viability and infectivity under different microenvironments when disassociated from its hosts during horizontal transmission, a critical phase of its life cycle.